Nelson, Van Denburg & Campbell Wealth Management Group, LLC Cytokinetics Inc Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.63 Billion
- Q4 2024
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 3,718 shares of CYTK stock, worth $174,076. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,718
Previous 3,999
7.03%
Holding current value
$174,076
Previous $211,000
17.54%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
405Shares Held
124MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$687 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$454 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$364 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$302 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.41B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...